Revolution Medicines, Inc.

RVMD Healthcare Biotechnology

Revolution Medicines, Inc.’s revenue for fiscal 2023 (year ended December 2023) was $11.6 million, down 67.3% from fiscal 2022. In the quarter to June 2026, EPS fell 133.6%, free cash flow fell 70.0% and total debt rose 322.7%, each against the same quarter a year earlier.

177.96 11.30 −5.97%
Market cap
$40.6B
P/E
0.0×
Fwd P/E
−11.9×
Dividend yield
—
F-score
4/9
Altman Z
7.73
Beneish M
−4.29
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
— — — —

+8 more quarters

EV/Sales
— — — —
EV/FCF
— — — —
Quick Ratio
11.12 6.59 6.97 7.86
Current Ratio
11.38 6.80 7.14 8.05
Net Debt/EBITDA
5.75 3.67 4.86 5.29
Debt/Assets
23.96% 12.45% 11.40% 11.39%
Debt/Equity
0.40 0.19 0.16 0.16
Asset Turnover
0.00 0.00 0.00 0.00
Operating CF/Net income
0.60 0.78 0.75 0.68
Capex/Depreciation
(13.69) (1.17) (13.01) 2.43
Interest Coverage
(21.24) (36.50) (30.30) (27.59)
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Intangible Assets out of Total Assets
0.02 0.03 0.03 0.03
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 0.00%
Free Cash Flow Yield
— — — —
Revenue per Share
0.00 0.00 0.00 0.00
Operating CF per Share
(1.84) (1.79) (1.44) (1.10)
Capex per Share
(0.01) (0.01) (0.01) (0.02)
Free Cash Flow per Share
(1.85) (1.80) (1.45) (1.11)
Cash per Share
18.67 9.63 10.65 10.21
Shareholders Equity per Share
12.36 7.57 8.58 8.44
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
12.36 7.57 8.58 8.44
Free Cash Flow
(389.60) (355.70) (276.16) (210.66)
Working Capital
3,674.28 1,678.31 1,784.61 1,731.87
Capital Expenditures
(2.29) (1.54) (1.92) (3.35)
Net Current Asset Value
2,311.31 1,214.09 1,351.83 1,322.47
EV/EBIT
— — — —
Capex to Sales
0.00 0.00 0.00 0.00
Other line items
Average Payables
72.59 64.02 59.52 49.65
Average Assets
3,376.42 2,309.55 2,456.40 2,007.46
Average Common Equity
2,235.80 1,789.03 1,948.25 1,581.60

Fold the line items

Columns are period end dates